Ludmila S Snegireva Selected Research

Lymphadenitis (Adenitis)

1/2022

The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ludmila S Snegireva Research Topics

Disease

3	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2022 - 01/2015
2	Shock 01/2022 - 01/2021
2	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2021
1	Aneurysm (Aneurysms) 01/2022
1	Dermatomyositis (Dermatopolymyositis) 01/2022
1	Lymphadenitis (Adenitis) 01/2022
1	Hypercholesterolemia 01/2022
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2022
1	Myocardial Infarction 01/2022
1	Rheumatic Diseases (Rheumatism) 01/2022
1	Thrombocytosis (Thrombocythemia) 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Uveitis 01/2022
1	Simian Acquired Immunodeficiency Syndrome 01/2022
1	Myocarditis (Carditis) 01/2021
1	Pleurisy (Pleuritis) 01/2021
1	Hypotension (Low Blood Pressure) 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021
1	Fever (Fevers) 01/2021
1	Proteinuria 02/2015
1	Cryopyrin-Associated Periodic Syndromes 09/2013

Drug/Important Bio-Agent (IBA)

3	Ferritins (Ferritin)IBA 01/2022 - 02/2015
3	tocilizumab (atlizumab)FDA Link 03/2018 - 09/2013
2	fibrin fragment D (D-dimer)IBA 01/2022 - 01/2021
1	EnzymesIBA 01/2022
1	N 30IBA 01/2022
1	tofacitinibIBA 01/2022
1	Etanercept (Enbrel)FDA Link 01/2022
1	Adalimumab (Humira)FDA Link 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	CreatinineIBA 01/2021
1	TroponinIBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	Cardiotonic Agents (Cardiac Stimulants)IBA 01/2021
1	Fibrinogen (Factor I)FDA Link 02/2015
1	AlbuminsIBA 02/2015